University of Guelph research published in the journal publication Blood has uncovered a surprising weakness in acute myeloid ...

For years, treatment of older patients with acute myeloid leukemia—an aggressive cancer of the blood and bone marrow—has ...

New findings presented at ASCO 2026 show that a CAR-T cell therapy called Breyanzi (lisocabtagene maraleucel) is producing ...

A life-threatening leukemia diagnosis forced Dr. David Zaas to experience healthcare from the other side of the hospital bed.

Emory University researchers are studying a treatment that doesn't blast the entire body, but instead, it's designed to find ...

A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by an innovative form of immune therapy. For families facing a disease that ...

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...

In an unprecedented intervention, Blood Cancer United announced that it has acquired the remaining supply of a promising ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment - immunotherapy - may help change the environment where cancer cells ...